Publikationen in Zusammenarbeit mit Forschern von Hospital de Cruces (78)

2024

  1. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

  2. Toward a Fair Adjusted Analysis of Kidney Graft Survival

    Transplantation

2023

  1. Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

    Transplantation Reviews, Vol. 37, Núm. 1

  2. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGIA (English Edition) (2022) 42(S2) (1–4), (S2013251422001444), (10.1016/j.nefroe.2022.01.009))

    Nefrologia

  3. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGÍA (2022) 42(S2) (129–132), (S0211699522000133), (10.1016/j.nefro.2022.01.007))

    Nefrologia

  4. Lymphoproliferative disorders after renal transplantation along 2 decades: A large longitudinal study of 21,546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  5. Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  6. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 6, pp. 1552-1559

  7. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients

    Nefrologia, Vol. 43, Núm. 5, pp. 531-545

2022

  1. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  2. Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study.

    Transplantation Proceedings, Vol. 54, Núm. 9, pp. 2462-2466

  3. Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation

    Clinical Kidney Journal, Vol. 15, Núm. 11, pp. 2039-2045

  4. Live donor kidney transplantation. Situation analysis and roadmap

    Nefrologia, Vol. 42, Núm. 1, pp. 85-93

  5. Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study

    Healthcare (Switzerland), Vol. 10, Núm. 12

  6. Recommendations for living donor kidney transplantation

    Nefrologia, Vol. 42, pp. 5-132

  7. Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients

    Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1847-1855

2021

  1. COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?

    Transplantation, Vol. 105, Núm. 10, pp. 2146-2155

  2. COVID-19 in transplant recipients: The Spanish experience

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Vol. 21, Núm. 5, pp. 1825-1837

  3. Molecular aspects and long-term outcome of patients with primary distal renal tubular acidosis

    Pediatric Nephrology, Vol. 36, Núm. 10, pp. 3133-3142

  4. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry

    American Journal of Transplantation, Vol. 21, Núm. 7, pp. 2573-2582